USA - New York Stock Exchange - NYSE:KRA - Common Stock
The current stock price of KRA is 46.49 null. In the past month the price increased by 0.74%. In the past year, price increased by 24.97%.
ChartMill assigns a technical rating of 7 / 10 to KRA. When comparing the yearly performance of all stocks, KRA is one of the better performing stocks in the market, outperforming 85.47% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to KRA. KRA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months KRA reported a non-GAAP Earnings per Share(EPS) of 2.86. The EPS increased by 121.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.45% | ||
| ROA | 7.66% | ||
| ROE | 25.51% | ||
| Debt/Equity | 1.03 |
10 analysts have analysed KRA and the average price target is 47.43 null. This implies a price increase of 2.02% is expected in the next year compared to the current price of 46.49.
For the next year, analysts expect an EPS growth of 12.54% and a revenue growth -0.57% for KRA
Kraton Corp. engages in the manufacture and marketing of styrenic block copolymers, specialty polymers, and other products primarily derived from pine wood pulping co-products. The company is headquartered in Houston, Texas and currently employs 1,751 full-time employees. The company went IPO on 2009-12-17. The firm manufactures styrenic block copolymers (SBCs), specialty polymers, and performance products primarily derived from pine wood pulping co-products. The firm operates through two segments: Polymer segment and Chemical segment. The Polymer segment, which comprises of its SBCs and other engineered polymers business. The Chemical segment is comprised of its pine-based specialty products business. The Company’s SBCs is an engineered synthetic elastomer, which is used in a range of applications, including adhesives, coatings, consumer and personal care products, sealants, lubricants, medical, packaging, automotive, paving and roofing, and others. The company also sells isoprene rubber (IR) and isoprene rubber latex (IRL), which are non-SBC products primarily used in applications such as medical products, personal care, adhesives, tackifiers, paints, and coatings. The company offers crude tall oil (CTO) and crude sulfate turpentine (CST).
Kraton Corporation
15710 John F Kennedy Blvd Ste 300
Houston TEXAS 77032 US
CEO: Kevin M. Fogarty
Employees: 1751
Phone: 18004572866.0
Kraton Corp. engages in the manufacture and marketing of styrenic block copolymers, specialty polymers, and other products primarily derived from pine wood pulping co-products. The company is headquartered in Houston, Texas and currently employs 1,751 full-time employees. The company went IPO on 2009-12-17. The firm manufactures styrenic block copolymers (SBCs), specialty polymers, and performance products primarily derived from pine wood pulping co-products. The firm operates through two segments: Polymer segment and Chemical segment. The Polymer segment, which comprises of its SBCs and other engineered polymers business. The Chemical segment is comprised of its pine-based specialty products business. The Company’s SBCs is an engineered synthetic elastomer, which is used in a range of applications, including adhesives, coatings, consumer and personal care products, sealants, lubricants, medical, packaging, automotive, paving and roofing, and others. The company also sells isoprene rubber (IR) and isoprene rubber latex (IRL), which are non-SBC products primarily used in applications such as medical products, personal care, adhesives, tackifiers, paints, and coatings. The company offers crude tall oil (CTO) and crude sulfate turpentine (CST).
The current stock price of KRA is 46.49 null. The price increased by 0.02% in the last trading session.
KRA does not pay a dividend.
KRA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on KRA.